Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective

Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective

Abstract GLP1 receptor agonists (GLP1-RAs) are drugs that mimic the effects of the incretin hormone GLP1 and were initially introduced in medicine for the treatment of diabetes in 2005 and for obesity in 2014. Over time, data from secondary and exploratory objectives of large randomized controlled-t...

Full description

Saved in:
Bibliographic Details
Main Authors: Jorge Rico-Fontalvo, Maricely Reina, María José Soler, Mario Unigarro-Palacios, Juan Pablo Castañeda-González, Javier Jiménez Quintero, María Raad-Sarabia, Thyago Proença de Moraes, Rodrigo Daza-Arnedo
Format: Article
Language:English
Published: Sociedade Brasileira de Nefrologia 2024-11-01
Series:Brazilian Journal of Nephrology
Subjects:
Albuminuria
Diabetes
Incretins
Obesity
Kidney disease
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002024000400405&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items